In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 31 for your search:
Drug:  cediranib maleate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00267, MGH-07-344, R01CA129371, CDR0000593717, PHS 398/2590, 8030, P30CA006516, 07-344, NCT00662506

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02937, 05-160, U01CA062490, CDR0000445438, DFCI-05160, 7099, NCI-7099, NCT00244881

3.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2013-01072, CDR0000446080, PHL-039, 7128, N01CM62203, PMH-PHL-039, NCI-7128, NCT00227760

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01822, N044J, CDR0000446081, NCCTG-N044J, U10CA025224, NCT00238394

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000446178, U10CA032102, S0509, SWOG-S0509, NCT00243074

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03026, PHL-038, N01CM62203, N01CM62201, PMH-PHL-038, 7137, NCT00243061

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02837, PHII-64, N01CM62201, N01CM62209, CCC-PHII-64, NCI-7097, 7097, NCT00245063

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00036, 05-170, U01CA062490, DFCI-05170, NCI-7102, 7102, NCT00275028

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03027, NCI-7129, PMH-PHL-037, PHL-037, 7129, N01CM62203, N01CM62209, N01CM62201, NCT00278343

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00127, 05-254, N02CO12400, CDR0000460079, MGH-05-254, NCI-7105, 7105, NCT00305656

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00126, N01CM17102, CDR0000463521, 14203B, UCCRC-14203B, NCI-7103, 7103, NCT00309946

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01825, NCCTG-N048F, U10CA025224, CDR0000467560, N048F, NCT00321724

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000468945, NCCTG-N0528, N0528, NCT00326599

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00128, CDR0000475761, MC047F, 7133, N01CM62205, MAYO-MC047F, NCI-7133, NCT00326872

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00165, 2006-042, CDR0000517316, U01CA062487, WSU-2006-042, 7389, NCT00410904

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 070059, 07-C-0059, NCI-07-C-0059, NCI-P6964, 7395, NCT00436956

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00148, CDR0000538287, MGH-06-264, 06-264, 7309, P30CA006516, R21CA119591, NCT00458978

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00129, CDR0000544833, MCCRC-MC048H, 7135, MC048H, N01CM62205, P30CA015083, NCT00475150

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00174, 2007-015, CDR0000564449, 7451, N01CM00038, U01CA062491, P30CA022453, U01CA062487, WSU-2007-015, NCT00527124

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000580967, CALGB-80502, NCT00588900

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02012, CDR0000665163, RTOG-0837, U10CA021661, RTOG-0837-ACRIN-6689, NCT01062425

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02043, GOG-0229J, U10CA027469, NCT01132820

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02535, CDR0000687126, CWRU-CASE-9209, CASE 9209, 8323, N01CM00070, U01CA062502, NCT01229111

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02544, PMH-PJC-002, CDR0000687955, PJC-002, 8476, U01CA070095, U01CA132123, N01CM00071, NCT01260688

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2009-00709, CDR0000476579, PBTC-020, U01CA081457, NCT00326664
1   
New Search